Cisplatin Plus Epinephrine in Treating Patients With Recurrent or Refractory Head and Neck Cancer

PHASE3UnknownINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 31, 1995

Conditions
Head and Neck Cancer
Interventions
DRUG

cisplatin-e therapeutic implant

Trial Locations (28)

21218

Veterans Affairs Medical Center - Baltimore, Baltimore

29203

Palmetto Richland Memorial Hospital, Columbia

33136

Sylvester Cancer Center, University of Miami, Miami

33462

Comprehensive Cancer Center at JFK Medical Center, Atlantis

37916

Thompson Cancer Survival Center, Knoxville

38119

Boston Cancer Group, Memphis

53226

Department of Otolaryngology, Milwaukee

60201

Evanston Northwestern Health Care, Evanston

63110

Washington University School of Medicine, St Louis

65109

Capitol Comprehensive Cancer Care Clinic, Jefferson City

68114

Methodist Cancer Center - Omaha, Omaha

70112

Louisiana State University Medical Center - New Orleans, New Orleans

78705

Southwest Regional Cancer Center, Austin

85723

Veterans Affairs Medical Center - Tucson, Tucson

85724

Arizona Cancer Center, Tucson

87131

University of New Mexico Cancer Research & Treatment Center, Albuquerque

94304

Veterans Affairs Medical Center - Palo Alto, Palo Alto

90095-1781

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

94115-0128

UCSF Cancer Center and Cancer Research Institute, San Francisco

94305-5408

Stanford University Medical Center, Stanford

66160-7357

University of Kansas Medical Center, Kansas City

40536-0084

University of Kentucky College of Medicine, Lexington

71130-3932

Louisiana State University Hospital - Shreveport, Shreveport

68131-2197

Creighton University Cancer Center, Omaha

97201-3098

Oregon Cancer Center at Oregon Health Sciences University, Portland

75235-9032

University of Texas Southwestern Medical School, Dallas

H3G 1A4

Montreal General Hospital, Montreal

H3G 1L5

Ville Marie Oncology Center, Montreal

Sponsors
All Listed Sponsors
lead

Matrix Pharmaceutical

INDUSTRY